Skip to main content
. 2016 Nov 25;8(1):1234–1246. doi: 10.18632/oncotarget.13603

Table 1. The selectivity of T521, Poloxin and TQ against the PBDs of Plk1-3 in vitro.

Plks PBD T521 Apparent IC50 Poloxin Apparent IC50 TQ Apparent IC50
Plk1 PBD 1.22±0.13 μM 4.27±0.69 μM 1.36±0.38 μM
Plk2 PBD >500 μM 15.62±2.26 μM 3.65±0.96 μM
Plk3 PBD >500 μM 46.68±3.55 μM 18.86±1.32 μM